Telephone
1.858.836.5000
Address
9001 Spectrum Center Boulevard San Diego, CA 92123
Description
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 27.13 - 40.75
Trade Value (12mth)
US$8,186,053.00
1 week
-1.07%
1 month
-4.67%
YTD
-10.06%
1 year
15.69%
All time high
40.79
EPS 3 yr Growth
112.60%
EBITDA Margin
34.20%
Operating Cashflow
$1,401m
Free Cash Flow Return
25.10%
ROIC
18.30%
Interest Coverage
26.60
Quick Ratio
1.70
Shares on Issue (Fully Dilluted)
1475m
HALO Sector
Healthcare
Next Company Report Date
31-Jul-25
Ex Dividend Date (est.)
12-Feb-25
Next Dividend Pay Date (est.)
20-Mar-25
Reporting Currency
USD
Short Sell (% of issue)
0.06
Date | Announcements |
---|---|
24 April 25 |
Resmed Announces Results for the Third Quarter of FY2025
×
Resmed Announces Results for the Third Quarter of FY2025 |
24 April 25 |
Dividend/Distribution - RMD
×
Dividend/Distribution - RMD |
15 April 25 |
Statement of changes in beneficial ownership of securities
×
Statement of changes in beneficial ownership of securities |
09 April 25 |
Notice of Proposed Sale of Securities
×
Notice of Proposed Sale of Securities |
08 April 25 |
Notice of Proposed Sale of Securities
×
Notice of Proposed Sale of Securities |
07 April 25 |
Statement of changes in beneficial ownership
×
Statement of changes in beneficial ownership |
04 April 25 |
Form 4 - Statement of Changes in Beneficial Ownership
×
Form 4 - Statement of Changes in Beneficial Ownership |
04 April 25 |
Statement of CDIs on issue - RMD
×
Statement of CDIs on issue - RMD |
03 April 25 |
ResMed to Report Third Quarter Fiscal 2025 Results
×
ResMed to Report Third Quarter Fiscal 2025 Results |
03 April 25 |
Report of proposed sale of securities
×
Report of proposed sale of securities |
02 April 25 |
Report of proposed sale of securities
×
Report of proposed sale of securities |
12 March 25 |
Form 4 - Statement of Changes in Beneficial Ownership
×
Form 4 - Statement of Changes in Beneficial Ownership |
12 March 25 |
NOTICE OF PROPOSED SALE OF SECURITIES
×
NOTICE OF PROPOSED SALE OF SECURITIES |
12 March 25 |
Statement of changes in beneficial ownership of securities
×
Statement of changes in beneficial ownership of securities |
12 March 25 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
×
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP |
11 March 25 |
Form 144 - Notice of Proposed Sale of Securities
×
Form 144 - Notice of Proposed Sale of Securities |
10 March 25 |
NOTICE OF PROPOSED SALE OF SECURITIES
×
NOTICE OF PROPOSED SALE OF SECURITIES |
07 March 25 |
Statement of changes in beneficial ownership of securities
×
Statement of changes in beneficial ownership of securities |
06 March 25 |
NOTICE OF PROPOSED SALE OF SECURITIES
×
NOTICE OF PROPOSED SALE OF SECURITIES |
05 March 25 |
Form 4 - Statement of Changes in Beneficial Ownership
×
Form 4 - Statement of Changes in Beneficial Ownership |
05 March 25 |
Form 4 - Statement of Changes in Beneficial Ownership
×
Form 4 - Statement of Changes in Beneficial Ownership |
04 March 25 |
Form 144 - Notice of Proposed Sale of Securities
×
Form 144 - Notice of Proposed Sale of Securities |
04 March 25 |
Form 144 - Notice of Proposed Sale of Securities
×
Form 144 - Notice of Proposed Sale of Securities |
04 March 25 |
Statement of CDIs on issue - RMD
×
Statement of CDIs on issue - RMD |
14 February 25 |
Update - Dividend/Distribution - RMD
×
Update - Dividend/Distribution - RMD |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.